MeiraGTx Holdings PLC (MGTX)
6.48
-0.16
(-2.41%)
USD |
NASDAQ |
Nov 15, 15:15
MeiraGTx Holdings Debt to Equity Ratio: 0.9079 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.9079 |
| March 31, 2024 | 0.5947 |
| December 31, 2023 | 0.5219 |
| September 30, 2023 | 0.7819 |
| June 30, 2023 | 0.5794 |
| March 31, 2023 | 0.7903 |
| December 31, 2022 | 0.6033 |
| September 30, 2022 | 0.5775 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2019
0.9079
Maximum
Jun 2024
0.2819
Average
--
Median
Dec 2019
Debt to Equity Ratio Benchmarks
| Heron Therapeutics Inc | -4.592 |
| Harmony Biosciences Holdings Inc | 0.3064 |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.4322 |
| IGC Pharma Inc | 0.0173 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 266.65M |
| Total Liabilities (Quarterly) | 186.61M |
| Shareholders Equity (Quarterly) | 80.04M |
| Current Ratio | 2.357 |
| Net Debt Paydown Yield | -0.10% |